Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 2
Journal homepage
216
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Nonthrombotic proliferative vasculopathy associated with antiphospholipid antibodies: A case report and literature review

Jeong Seok LeeDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, ;Department of Pathology, Seoul National University Hospital, Seoul, Korea, and ORCID Iconhttp://orcid.org/0000-0001-8261-7044
ORCID Icon,
Hyojin KimDepartment of Pathology, Seoul National University Hospital, Seoul, Korea, and ORCID Iconhttp://orcid.org/0000-0001-9201-8328
ORCID Icon,
Eun Bong LeeDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, ORCID Iconhttp://orcid.org/0000-0003-0703-1208
ORCID Icon,
Yeong Wook SongDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, ;Department of Molecular Medicine and Biopharmaceutical Sciences, BK 21 plus Graduate School of Convergence Science and Technology, College of Medicine, Medical Research Institute, Seoul National University, Seoul, KoreaORCID Iconhttp://orcid.org/0000-0002-5384-3437
ORCID Icon &
Jin Kyun ParkDivision of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, ;Department of Molecular Medicine and Biopharmaceutical Sciences, BK 21 plus Graduate School of Convergence Science and Technology, College of Medicine, Medical Research Institute, Seoul National University, Seoul, KoreaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2167-9393
ORCID Icon
Pages 388-392 | Received 15 Mar 2016, Accepted 26 Jul 2016, Published online: 18 Aug 2016

References

  • Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med. 2013;368(11):1033–44.
  • Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91(10):3527–61.
  • Hughson MD, McCarty GA, Brumback RA. Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome. Hum Pathol. 1995;26(7):716–24.
  • Espinosa G, Cervera R, Font J, Asherson RA. The lung in the antiphospholipid syndrome. Ann Rheum Dis. 2002;61(3):195–8.
  • Alarcon-Segovia D, Cardiel MH, Reyes E. Antiphospholipid arterial vasculopathy. J Rheumatol. 1989;16(6):762–7.
  • Futrell N, Asherson RA, Lie JT. Probable antiphospholipid syndrome with recanalization of occluded blood vessels mimicking proliferative vasculopathy. Clin Exp Rheumatol. 1994;12(2):230–1.
  • Patel YI, St John A, McHugh NJ. Antiphospholipid syndrome with proliferative vasculopathy and bowel infarction. Rheumatology (Oxford). 2000;39(1):108–10.
  • Reyes E, Alarcon-Segovia D. Leg ulcers in the primary antiphospholipid syndrome. Report of a case with a peculiar proliferative small vessel vasculopathy. Clin Exp Rheumatol. 1991;9(1):63–6.
  • Sanchez-Guerrero J, Reyes E, Alarcon-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol. 1992;19(4):623–5.
  • Juergens JL. Chronic occlusive arterial disease of the extremities. Circulation 1963;27:964–9.
  • Park JK, Park EA, Lee W, Kim YK, Lee EY, Song YW, et al. Baseline MRA predicts the treatment response to vasodilator udenafil in patients with secondary Raynaud's phenomenon. Clin Exp Rheumatol. 2014;32(6 Suppl 86):S-167–70.
  • Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B, et al. Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol. 2005;23(2):199–204.
  • Boin F, Franchini S, Colantuoni E, Rosen A, Wigley FM, Casciola-Rosen L. Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients. Arthritis Rheum. 2009;60(8):2480–9.
  • Ichikawa H, Amano T, Fukuda S, Kataoka H, Kawabata K, Nagake Y, et al. [A case of scleroderma renal crisis with massive pericardial effusion and positivity on antiphospholipid antibody test]. Nihon Jinzo Gakkai Shi. 1998;40(4):295–300.
  • Willis R, Gonzalez EB, Brasier AR. The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome. Curr Rheumatol Rep. 2015;17(3):16.
  • Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2003;1:497–519.
  • Allen KL, Fonseca FV, Betapudi V, Willard B, Zhang J, McCrae KR. A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. Blood. 2012;119(3):884–93.
  • Canaud G, Bienaime F, Tabarin F, Bataillon G, Seilhean D, Noel LH, et al. Inhibition of the mTORC pathway in the antiphospholipid syndrome. N Engl J Med. 2014;371(4):303–12.
  • Poulton K, Rahman A, Giles I. Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. Semin Arthritis Rheum. 2012;41(5):720–36.
  • Canaud G, Bienaime F, Noel LH, Royal V, Alyanakian MA, Dautzenberg MD, et al. Severe vascular lesions and poor functional outcome in kidney transplant recipients with lupus anticoagulant antibodies. Am J Transplant. 2010;10(9):2051–60.
  • Pattanaik D, Brown M, Postlethwaite AE. Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res. 2011;4:105–25.
  • Edelman ER, Danenberg HD. Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds? Circulation. 2003;108:6–8.
  • Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008;117(16):2131–41.
  • Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115(8):1051–8.
  • Urbanus RT, Pennings MT, Derksen RH, de Groot PG. Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2′. J Thromb Haemost. 2008;6(8):1405–12.
  • Li L, Blumenthal DK, Terry CM, He Y, Carlson ML, Cheung AK. PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. J Cell Biochem. 2011;112(1):289–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.